LCM
RGNX icon

Laurion Capital Management’s Regenxbio RGNX Stock Holding History

Laurion Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,188
Closed -$78.8K – 367
2024
Q4 		$78.8K Buy
+10,188
New +$95.7K ﹤0.01% 271
2018
Q4 		– Sell
-3,093
Closed -$234K – 1354
2018
Q3 		$234K Buy
+3,093
New +$223K ﹤0.01% 1002
2017
Q3 		– Sell
-123,028
Closed -$2.43M – 1855
2017
Q2 		$2.43M Buy
123,028
+95,928
+354% +$1.86M 0.01% 754
2017
Q1 		$523K Buy
+27,100
New +$523K ﹤0.01% 894
2015
Q4 		– Sell
-27,000
Closed -$595K – 1028
2015
Q3 		$595K Buy
+27,000
New +$689K 0.01% 427

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Laurion Capital Management's RGNX Position: Q1 2025 in Review

Laurion Capital Management sold out of Regenxbio (RGNX) in Q1 2025, closing a stake of 10,188 shares — an estimated $78.8K sold.

Laurion Capital Management first reported a position in RGNX in Q3 2015 and held it in 5 quarters. The position peaked at $2.43M in Q2 2017. 164 funds tracked by Wall St. Rank hold RGNX as of Q1 2025.

  • Laurion Capital Management reported no remaining Regenxbio position as of Q1 2025 after selling out during the quarter.
  • Laurion Capital Management sold 10,188 Regenxbio shares in Q1 2025, an estimated $78.8K.
  • Laurion Capital Management first reported a position in Regenxbio in Q3 2015 and held it in 5 quarters.
  • Laurion Capital Management's Regenxbio position peaked at $2.43M in Q2 2017.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q1 2025.

Based on Laurion Capital Management's 13F filing for Q1 2025, filed 15 May 2025.